Literature DB >> 9177378

Altered ionic effects of insulin in hypertension: role of basal ion levels in determining cellular responsiveness.

M Barbagallo1, R K Gupta, O Bardicef, M Bardicef, L M Resnick.   

Abstract

To investigate the ionic actions of insulin in hypertension, 19F- and 31P-nuclear magnetic resonance spectroscopy were used to measure cytosolic free calcium (Ca(i)) and intracellular free magnesium (Mg(i)) levels in red blood cells from normal (n = 9) and hypertensive (n = 9) subjects before and 30, 60, 120, and 180 min after in vitro incubation with insulin. In hypertensive patients, basal Ca(i) levels were significantly higher (30.0 +/- 2.2 vs. 19.8 +/- 2.5 nmol/L; P < 0.05), and basal Mg(i) levels were significantly lower (170 +/- 10.9 vs. 209 +/- 8 micromol/L; P < 0.05) than in normotensive subjects. In normal cells, insulin significantly elevated Ca(i) to 39.8 +/- 8.0, 50.1 +/- 8.2, 69.3 +/- 11.1, and 50.9 +/- 13.4 nmol/L at 30, 60, 120, and 180 min and Mg(i) to 238 +/- 10,264 +/- 14,226 +/- 11, and 216 +/- 10 micromol/L at 30, 60, 120, and 180 min. In hypertensive subjects, the insulin-dependent Ca(i) elevation was blunted, and Mg(i) accumulation was completely suppressed. Continuous relationships were observed between basal values of each ion and insulin responses; the greater the Ca(i), the less the Ca(i) rose (r = -0.574; P = 0.013), and the lower the Mg(i), the less Mg(i) rose (r = 0.524; P = 0.025). Furthermore, a blunting of Mg(i) responses to insulin could be reproduced in normal cells that were magnesium depleted by prior treatment either with A23187 in a calcium-free medium or with high glucose concentrations (15 mmol/L). Once again, insulin responsiveness followed basal Mg(i) levels (r = 0.637; P < 0.001). Together, these data demonstrate ionic aspects of insulin resistance in hypertension and suggest that Ca(i) and Mg(i) levels may regulate cellular responsiveness to insulin. This may help to explain the different vascular actions attributed to insulin in normal compared with insulin-resistant states such as hypertension.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9177378     DOI: 10.1210/jcem.82.6.4022

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

Review 1.  The use of selected nutrition supplements and complementary and alternative medicine in liver disease.

Authors:  A James Hanje; Brett Fortune; Ming Song; Daniell Hill; Craig McClain
Journal:  Nutr Clin Pract       Date:  2006-06       Impact factor: 3.080

Review 2.  Effects of thiazolidinediones on blood pressure.

Authors:  Thomas D Giles; Gary E Sander
Journal:  Curr Hypertens Rep       Date:  2007-08       Impact factor: 5.369

3.  Intracellular magnesium of obese and type 2 diabetes mellitus children.

Authors:  Junji Takaya; Fumiko Yamato; Yuichi Kuroyanagi; Hirohiko Higashino; Kazunari Kaneko
Journal:  Diabetes Ther       Date:  2010-10-26       Impact factor: 2.945

4.  Erythrocyte intracellular Mg(2+) concentration as an index of recognition and memory.

Authors:  Wenxiang Xiong; Yaru Liang; Xue Li; Guosong Liu; Zhao Wang
Journal:  Sci Rep       Date:  2016-06-02       Impact factor: 4.379

Review 5.  Role of Magnesium Deficiency in Promoting Atherosclerosis, Endothelial Dysfunction, and Arterial Stiffening as Risk Factors for Hypertension.

Authors:  Krasimir Kostov; Lyudmila Halacheva
Journal:  Int J Mol Sci       Date:  2018-06-11       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.